PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
503.87 - 512.55
344.79 - 555.45
23.62M / 20.39M (Avg.)
37.30 | 13.67
Helps investors judge whether earnings growth is driven by sustainable operations or temporary factors. Consistent, organic income expansion can justify a higher intrinsic value for patient, long-term investors.
-3.33%
Revenue decline while CRWD shows 22.14% growth. Joel Greenblatt would examine competitive position erosion.
1.67%
Cost growth 1.25-1.5x CRWD's 1.17%. Martin Whitman would scrutinize competitive cost position.
-5.72%
Gross profit decline while CRWD shows 42.71% growth. Joel Greenblatt would examine competitive position.
-2.48%
Margin decline while CRWD shows 16.84% expansion. Joel Greenblatt would examine competitive position.
1.12%
R&D growth less than half of CRWD's 10.59%. David Dodd would verify if efficiency advantage is sustainable.
-9.60%
G&A reduction while CRWD shows 10.72% growth. Joel Greenblatt would examine efficiency advantage.
-13.91%
Marketing expense reduction while CRWD shows 6.86% growth. Joel Greenblatt would examine competitive risk.
122.95%
Other expenses change of 122.95% while CRWD maintains costs. Bruce Berkowitz would investigate efficiency.
-7.43%
Operating expenses reduction while CRWD shows 8.24% growth. Joel Greenblatt would examine advantage.
-2.93%
Total costs reduction while CRWD shows 6.44% growth. Joel Greenblatt would examine advantage.
0.30%
Interest expense change of 0.30% while CRWD maintains costs. Bruce Berkowitz would investigate control.
12.76%
D&A growth 50-75% of CRWD's 24.52%. Bruce Berkowitz would examine asset strategy.
-7.76%
EBITDA decline while CRWD shows 9.27% growth. Joel Greenblatt would examine position.
8.70%
EBITDA margin growth below 50% of CRWD's 27.89%. Michael Burry would check for structural issues.
-4.09%
Operating income decline while CRWD shows 9.94% growth. Joel Greenblatt would examine position.
-0.78%
Operating margin decline while CRWD shows 26.26% growth. Joel Greenblatt would examine position.
-11.63%
Both companies reducing other expenses. Martin Whitman would check industry patterns.
-4.30%
Pre-tax income decline while CRWD shows 9.49% growth. Joel Greenblatt would examine position.
-1.00%
Pre-tax margin decline while CRWD shows 25.90% growth. Joel Greenblatt would examine position.
-22.69%
Both companies reducing tax expense. Martin Whitman would check patterns.
-0.55%
Net income decline while CRWD shows 19.42% growth. Joel Greenblatt would examine position.
2.87%
Net margin growth below 50% of CRWD's 34.02%. Michael Burry would check for structural issues.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-0.13%
Share count reduction while CRWD shows 297.64% change. Joel Greenblatt would examine strategy.
-0.12%
Diluted share reduction while CRWD shows 297.64% change. Joel Greenblatt would examine strategy.